alpha-cyano-4-hydroxycinnamate has been researched along with Coronary Disease in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasser, RN | 1 |
| Vaughan-Jones, RD | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Coronary Disease
| Article | Year |
|---|---|
Mechanism of potassium efflux and action potential shortening during ischaemia in isolated mammalian cardiac muscle.
Topics: Action Potentials; Animals; Bumetanide; Chlorides; Coronary Disease; Coumaric Acids; Deoxyglucose; F | 1990 |